Literature DB >> 12823173

Neuropsychological and neurophysiological findings in individuals suspected to be at risk for schizophrenia: preliminary results from the Basel early detection of psychosis study - Früherkennung von Psychosen (FEPSY).

U Gschwandtner1, J Aston, S Borgwardt, M Drewe, C Feinendegen, D Lacher, A Lanzarone, R-D Stieglitz, A Riecher-Rössler.   

Abstract

OBJECTIVE: Our study aims to establish a scientific basis for the very early detection of patients at risk for schizophrenia during the nonspecific prodromal phase of the disorder and to predict its outbreak.
METHOD: A multidomain approach is used. After screening, approved psychopathological, neurophysiological, neuropsychological and neuroradiological investigations are used to assess a sample of individuals suspected to be at risk for schizophrenia.
RESULTS: Neuropsychological and fine motor functioning tests as well as eye movement measurements showed statistically significant differences (P<0.01) between individuals suspected to be at risk for schizophrenia and healthy controls.
CONCLUSION: Individuals suspected to be at risk for schizophrenia show specific impairments in various investigations including neuropsychological and fine motor functioning tests as well as eye movement measurements. A set of methods sensitive to even subtle changes in normal functioning may prove useful in predicting the subsequent outbreak of schizophrenia.

Entities:  

Mesh:

Year:  2003        PMID: 12823173     DOI: 10.1034/j.1600-0447.2003.00157.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  19 in total

1.  Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Authors:  Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt
Journal:  Arch Gen Psychiatry       Date:  2010-06

Review 2.  Assessment of adolescents at risk for psychosis.

Authors:  Karin Borgmann-Winter; Monica E Calkins; Kathryn Kniele; Raquel E Gur
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

3.  Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.

Authors:  A D Eastvold; R K Heaton; K S Cadenhead
Journal:  Schizophr Res       Date:  2007-04-30       Impact factor: 4.939

Review 4.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis.

Authors:  Christopher R Bowie; Danielle McLaughlin; Ricardo E Carrión; Andrea M Auther; Barbara A Cornblatt
Journal:  Schizophr Res       Date:  2012-02-28       Impact factor: 4.939

Review 6.  Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis.

Authors:  Warrick J Brewer; Stephen J Wood; Lisa J Phillips; Shona M Francey; Christos Pantelis; Alison R Yung; Barbara Cornblatt; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2006-06-16       Impact factor: 9.306

7.  The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome.

Authors:  Scott W Woods; Barbara C Walsh; John R Saksa; Thomas H McGlashan
Journal:  Schizophr Res       Date:  2010-09-15       Impact factor: 4.939

8.  Neurocognition and conversion to psychosis in adolescents at high-risk.

Authors:  D J Walder; V Mittal; H D Trotman; A L McMillan; E F Walker
Journal:  Schizophr Res       Date:  2008-02-20       Impact factor: 4.939

9.  Is there a degenerative process going on in the brain of people with Schizophrenia?

Authors:  Bjørn Rishovd Rund
Journal:  Front Hum Neurosci       Date:  2009-10-26       Impact factor: 3.169

10.  Cannabis use and cognition in schizophrenia.

Authors:  Else-Marie Løberg; Kenneth Hugdahl
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.